rs121908980
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_001164279.2(SLC37A4):c.797G>A(p.Gly266Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,298 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G266C) has been classified as Pathogenic.
Frequency
Consequence
NM_001164279.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164277.2 | c.1016G>A | p.Gly339Asp | missense_variant | 10/11 | ENST00000642844.3 | NP_001157749.1 | |
SLC37A4 | NM_001164279.2 | c.797G>A | p.Gly266Asp | missense_variant | 10/11 | NP_001157751.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC37A4 | ENST00000330775.9 | c.1016G>A | p.Gly339Asp | missense_variant | 9/10 | 5 | ENSP00000476242 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459298Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 725742
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Glucose-6-phosphate transport defect Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2000 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 24, 2022 | Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 339 of the SLC37A4 protein (p.Gly339Asp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with glycogen storage disease type 1b (PMID: 10931421, 15669677). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.G339D in the G6PT or G6PT1 gene. ClinVar contains an entry for this variant (Variation ID: 6935). Experimental studies have shown that this missense change affects SLC37A4 function (PMID: 12444104). This variant disrupts the p.Gly339 amino acid residue in SLC37A4. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9428641, 9758626, 10482962, 10923042). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 19, 2022 | - - |
not provided Pathogenic:1Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2023 | SLC37A4: PM2, PM5, PS4:Moderate, PP3, PS3:Supporting - |
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Glucose-6-phosphate transport defect;C0342749:Phosphate transport defect;C5561986:Congenital disorder of glycosylation, type IIw Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 17, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at